| 11485737 |
Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Venkat Reddy Mali +3 more |
2022-11-01 |
| 11485708 |
Compounds for treatment of PD-L1 diseases |
Viengkham Malathong, Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie +4 more |
2022-11-01 |
| 11479553 |
5-5 fused rings as C5a inhibitors |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Venkat Reddy Mali +2 more |
2022-10-25 |
| 11478460 |
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors |
Pingchen Fan, Christopher W. Lange, Viengkham Malathong, Venkat Reddy Mali, Sreenivas Punna +2 more |
2022-10-25 |
| 11446289 |
Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors |
Shijie LI, Venkat Reddy Mali, Rajinder Singh, Ju Yang |
2022-09-20 |
| 11434230 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Manmohan Reddy Leleti, Rebecca M. Lui +6 more |
2022-09-06 |
| 11427541 |
Salt forms of a complement component C5A receptor |
Rajinder Singh, Kwok YAU, Yibin Zeng, Rebecca M. Lui, Ju Yang +1 more |
2022-08-30 |
| 11426364 |
Immunomodulator compounds |
Christopher W. Lange, Viengkham Malathong, Darren McMurtrie, Sreenivas Punna, Rajinder Singh +1 more |
2022-08-30 |
| 11384079 |
6-5 fused rings as C5a inhibitors |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Venkat Reddy Mali +4 more |
2022-07-12 |
| 11266643 |
Triaryl compounds for treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie, Viengkham Malathong +4 more |
2022-03-08 |
| 11254695 |
Soluble C5aR antagonists |
Pingchen Fan, Antoni Krasinski, Venkat Reddy Mali, Shichang Miao, Sreenivas Punna +3 more |
2022-02-22 |